📰 Michael Polyviou News
Page 2 - Michael Polyviou News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Polyviou. Real-time updates on events, politics, business and more.
November 6, 2023
IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that in parallel with the growing adoption of ProSense®, the number of independent, non-sponsored studies of its cryoablation system has significantly increased. In addition to the 12 studies already published in peer reviewed jou...
October 27, 2023
PARSIPPANY, N.J., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC) (“Lincoln”) announced today that it will host...
October 5, 2023
/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation...
October 2, 2023
IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that new data was presented at the European Society of Breast Imaging ("EUSOBI") Scientific Meeting in Valencia, Spain by Lucía Graña-López, MD, PhD, principal investigator of the independent, non-sponsored stu...
September 22, 2023
Growing body of evidence-based data is giving women a minimally invasive alternative to the standard of care lumpectomyPatients throughout the European Union have access to ProSense for the...
September 8, 2023
/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation...
August 21, 2023
Professor Eisuke Fukuma, who has performed over 600 ProSense breast cancer cryoablation procedures, led a cryoablation symposium with ProSenseIceCure joined its exclusive regional distributor,...
August 14, 2023
IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today reported financial results as of and for the six months ended June 30, 2023, as well as operational and recent corporate developments.
August 8, 2023
Operator: Good day and welcome to the Q2 2023 Lincoln Educational Services Earnings Conference Call. [Operator Instructions] Please be advised that todays conference is being recorded.
August 7, 2023
PARSIPPANY, N.J., Aug. 07, 2023 -- Lincoln Educational Services Corporation today announced financial and operating results for the second quarter as well as recent business developments. Second...